SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
ULBI 6.460+1.7%3:17 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: richardred12/7/2004 1:47:39 AM
  Read Replies (1) of 7265
 
A Possible Mega Merger

J&J in talks to buy Guidant for $24 bln - NY Times
Tue Dec 7, 2004 01:13 AM ET
NEW YORK, Dec 7 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile, Research) is in advanced talks to buy cardiovascular device maker Guidant Corp. (GDT.N: Quote, Profile, Research) for more than $24 billion, the New York Times reported on Tuesday.
The discussions have reached a sensitive point and a potential deal could still fall through because of the price, among other things, executives close to the talks told the newspaper.

There is hope that a final deal can be reached in the next week, according to the Times.

A deal would be the third-biggest in the United States this year behind J.P. Morgan Chase's (JPM.N: Quote, Profile, Research) $58 billion acquisition of Bank One and Cingular's (SBC.N: Quote, Profile, Research) (BLS.N: Quote, Profile, Research) $41 billion purchase of AT&T Wireless, the Times said.

It would also give Johnson & Johnson, based in New Brunswick, New Jersey, a significant presence in the market for defibrillators, pacemakers and similar products, the paper added.

Johnson & Johnson and Guidant could not be immediately reached for comment.

yahoo.reuters.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext